Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury
Key facts
- Who runs it
- Gillette Children's Specialty Healthcare
- Where
- Minneapolis and Saint Paul, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 7 people enrolled
- Started
- 16 May 2022
- Ended
- 31 Dec 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Ketogenic Diet
- Record updated
- 12 February 2026
Who can take part
- Age
- 2 years to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age limits met at the time of injury and admission
- Participants with moderate to severe traumatic brain injury defined as a Glasgow Coma Scale Score of 3-12 (lowest score in the first 24 hours after injury). Individuals requiring craniotomy and/or evacuation of intracranial hemorrhage may be included
Who cannot take part
- Currently on an oral diet at time of screening or currently on IV-only and in opinion of Pediatric Intensive Care Unit intensivist will be transitioning to an oral diet, not tube-feeding
- Any condition that in the opinion of the Pediatric Intensive Care Unit or neurosurgery medical staff warrants exclusion from the study
- Anoxia/ischemia as a significant portion of injury, including near-drowning
- Non-accidental traumatic brain injury (i.e., assault, abuse)
- Penetrating injury including gunshot wounds
- Pregnancy
Where in United States
- Children's MinnesotaMinneapolis, United States
- Gillette Children's Specialty HealthcareSaint Paul, United States
About the trial
What the trial wants to find out
The primary objective of this study is to evaluate the feasibility and safety of using the ketogenic diet (KD) in children who sustained moderate to severe traumatic brain injury (TBI). The secondary objective is a preliminary evaluation of the outcomes of children who have had the standard of care plus the KD, compared to those with standard of care alone. Outcome measures for the secondary objective will include: need for ventriculoperitoneal shunt, duration of unconsciousness, need for any type of craniotomy, duration of post-traumatic amnesia, acute hospitalization length of stay, and cognitive and motor function at 12 months after injury. If this study demonstrates feasibility and safety, the information related to outcomes will be used to inform the planning of a future, larger, randomized study of the efficacy of the KD in children and adolescents with TBI. Specifically, this information will be used to assist with sample size calculations for this future study.
The 2 groups in the trial
- Prospective Intervention GroupTreatment being tested
Participants will receive standard of care for acute management of moderate to severe traumatic brain injury, together with a weight-based ketogenic diet added for up to fourteen days.
Treatment: Ketogenic Diet
- Historical Control GroupNo study treatment, for comparison
Medical records of past TBI patients will be used as controls matched for age, gender, socioeconomic status (type of health care coverage including private insurance vs. government-funded coverage), lowest first 24 hour post-injury Glasgow Coma Score (GCS) (\<8 or 8-12), and pre-injury school program (regular or special education).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury: A Pilot Study
- Record updated
- 12 February 2026